Vertex Pharmaceuticals Incorporated (VRTX)
60/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $122.3B
- P/E
- 28.6
- Sector Median P/E
- 25.5
- F-Score
- 6/9
- ROIC
- 4.1%
- FCF Yield
- 2.8%
Tessera scores VRTX (Vertex Pharmaceuticals Incorporated) at 59/100 — top 50% of the Healthcare sector. VRTX trades at a P/E of 28.6, 12% above the sector median of 25.5. Piotroski F-Score is 6/9; trailing ROIC is 4.1%.
Sector Peers
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $68.3B · FCF: 27.9%
- argenx SE (ARGX)Mkt Cap: $54.8B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%
- Alnylam Pharmaceuticals, Inc. (ALNY)Mkt Cap: $41.5B · FCF: 15.0%